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The vascular endothelial growth factor (VEGF) family binds multiple endothelial cell surface receptors. Our goal is to build comprehensive
models of these interactions for the purpose of simulating angiogenesis. In view of low concentrations of growth factors in vivo and in vitro,
stochastic modeling of molecular interactions may be necessary. Here, we compare Monte Carlo simulations of the stochastic binding of VEGF
and two of its major receptors on cells in vitro to equivalent deterministic simulations. In the range of typical VEGF concentrations, the stochastic
and deterministic models are in agreement. However, we observe significant variability in receptor binding, which may be linked to biological
stochastic events, e.g., blood vessel sprout initiation. We study patches of cell surface of varying sizes to investigate spatial integration of the
signal by the cell, which impacts directly the variability of binding, and find significant variability up to the single-cell level. Dimerization of
VEGF receptors does not significantly alter the variability in ligand binding. A Fsliding window_ approach demonstrated no reduction in the
variability of binding by temporal integration. The variability is expected to be more prominent in in vivo situations where the number of ligand
molecules available for binding is less.
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Angiogenesis (neovascularization) is a vital process for
physiological growth, development and wound healing, as well
as for pathologies such as cancer and diabetic retinopathy. Many
biological molecules are involved in the regulation of angiogen-
esis including multiple growth factor families, matrix metallo-
proteinases, heparan sulfate proteoglycans, integrins, and
endothelial cell-surface receptor tyrosine kinases. Parenchymal
cells, in response to low oxygen or other stressors, release
cytokines such as vascular endothelial growth factor (VEGF).
These glycoproteins diffuse through the interstitial space to
endothelial cells that form capillaries, where they bind to and
activate receptors on the endothelial cells. This can lead to
extracellular matrix proteolysis, endothelial cell migration,
proliferation and formation of new capillary networks. In vitro,
these growth factors have significant impact on cultured
endothelial cells, increasing survival, migration and proliferation.
Computational models have been used to study different
aspects of the angiogenic process. One kinetic model describes0167-4889/$ - see front matter D 2005 Elsevier B.V. All rights reserved.
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factor in in vitro assays [1]; another includes VEGF isoforms
and their interactions with VEGF receptor 2 and neuropilin-1
[2]. Concentrations of VEGF used in such assays typically
range from 10 pM to 10 nM. Physiological concentrations of
many molecules involved in angiogenesis are in the picomolar
range; in one study, VEGF protein concentration in rat organs
ranged from 22 pM (spleen) to 21 nM (omentum), with 140
pM and 760 pM in heart and skeletal muscle, respectively [3].
Mean VEGF concentrations (measured across many patients)
of 2–7 pM were found in the avascular spinal cord [4]. Blood
VEGF is also low; in plasma, 1–10 pM [5,6]; in serum, 3–5
pM [7]. These are means; individuals may have even lower
concentrations. Sub-nanomolar concentrations equate to less
than one ligand molecule in each cubic micron of fluid. In view
of these low concentrations, there are two fundamental
questions to be asked. First, are the predictions of a
deterministic model based on the continuum approximation
valid at low ligand concentrations? The continuum approach
assumes that the density of molecules is large enough to be
represented by a concentration rather than tracking individual
molecules. A failure of the continuum approximation would be
observed as a divergence of the mean of many stochastica 1746 (2005) 95 – 107
http://www
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the variability of receptor-ligand binding around the mean? The
deterministic model describes the average behavior of the
system; however, at low concentrations, the variance of
ligand–receptor interactions in such an environment could be
very significant. This variance could result in localized
responses to growth factors, if the response is based on a
threshold function [8]. For example, with low variance, all cells
(or all areas of a cell) exposed to the same VEGF concentration
will have an equivalent number of ligand–receptor complexes
formed; if the variance is high, cells will demonstrate varying
levels of complex formation, and thus varying levels of
signaling. If the cell only responds (e.g., proliferates or
migrates) when the signal reaches a threshold level, some cells
will respond and not others; whereas, with low variability, all
cells will respond identically.
Stochastic approaches have been used to study similar
systems and non-system-specific ligand–receptor interactions.
In systems with extremely low (attomolar) ligand concentra-
tions, the coefficient of variation was found to be highly
dependent on the reaction scheme, and could be used to
discriminate between cooperative and non-cooperative models
of ligand–receptor interaction [9]. In that model, analytical
equations were derived for the binding probabilities, but that
approach could not be used to produce results for our scenario,
as it requires that ligand be in excess over receptor, which is not
always the case here. Deriving analytical probabilistic equa-
tions that incorporated association and dissociation binding rate
constants and multiple receptor types would be a significant
challenge. Other stochastic models describe autocrine and
paracrine ligand trapping distance from the point of secretion
for epithelial layers and cell cultures [10,11], however,
analytical expressions for the binding of ligands to the
receptors are not available. In order to study the variance of
VEGF ligand–receptor interactions under different in vitro
conditions, we have employed two Monte Carlo simulation
approaches. The first uses the MCell software [12] (http://
www.mcell.cnl.salk.edu). With MCell, the VEGF molecules
move in a three-dimensional space and bind to receptors that
are immobilized on a two-dimensional surface; thus this is
similar to simulating in vitro experiments with a partial
differential equation. The second uses the Gillespie algorithm
[13]. This method includes the kinetics of ligand–receptor
binding but does not include the diffusion of molecules and
thus is similar to an ordinary differential equation description.
The extension of this analysis to an in vivo situation is not part
of this study. This is the first study to compare the deterministic
and stochastic results for a kinetic model of binding of this
growth factor-receptor family.
In all the simulations, we have focused on one common
isoform of VEGF (VEGF165) and two of its receptors,
VEGFR1 (Flt-1) and VEGFR2 (KDR/Flk-1) (for reviews, see
refs. [14–16]). A range of ligand concentrations was studied,
and the ratio of the two receptors was varied. Results of
stochastic simulations are compared with the results of
deterministic simulations performed using the full kinetic
method described previously [1] that takes into account thegradients of ligands in the medium above the cell monolayer. If
the cell integrates the signal coming from multiple receptors in
a local area, the stochastic properties of the signal would
depend on the area of interest. To compare the simulations, we
used fractional occupancy of each receptor type (VEGFR1 or
VEGFR2) in that area of cell membrane as a measure of
binding, comparing the prediction of the deterministic simula-
tion with the mean of many runs of the stochastic simulation.
For the deterministic model, the size of the membrane does not
affect the result; however, the size of this area will determine
the number of receptors the cell is integrating, and thus the
variability of the integrated signal. We calculated the coeffi-
cient of variation for the stochastic simulation as a measure of
the variability in the binding.
2. Methods
2.1. Deterministic model
The deterministic, kinetic model was based on the models of in vitro
experiments developed previously [1,2]. In brief, the receptors are assumed to
be uniformly distributed over the surface of the cell, and the ligand
concentration is assumed to be uniform in the planes parallel to the surface,
varying only in the direction normal to the endothelial monolayer. Gradients are
allowed to develop in this direction. Ligands diffuse through the medium and
bind to receptors forming ligand– receptor complexes. Ligands can be released
from these receptors, or they may be internalized. In these simulations of in
vitro cell cultures at 4 -C, it is assumed that no internalization takes place. The
resulting coupled set of partial differential equations was non-dimensionalized;
a fully implicit finite-difference scheme was applied, and implemented on a PC.
2.2. 3D stochastic software
MCell (http://www.mcell.cnl.salk.edu), a general Monte Carlo simulator of
cellular microphysiology was used for three-dimensional stochastic simula-
tions. Programming was done using a custom Model Description Language
(MDL) built into MCell. UNIX shell scripting and FORTRAN coding were
used for simulation automation and data analysis, respectively.
2.3. Simulated environment
In in vitro experiments, a monolayer of endothelial cells is covered by a
layer of fluid medium approximately 1000 Am thick. Ligands are initially
uniformly dispersed within this fluid. Endothelial cells have approximately
1000 Am2 of ‘‘lumenal’’ surface area [1]. For the simulations, cell surface
sections of 1 Am1 Am and 2 Am2 Am were selected. Thus the dimensions
of the simulation environments were 1 Am1 Am1000 Am and 2 Am2
Am1000 Am.
An endothelial cell typically has 1–100 VEGFR1 or VEGFR2 receptors/
Am2 [17–20]. For the simulations, these two receptors were placed in different
ratios on the cell surface sections. MCell uses a barycentric subdivision method
to divide the cell surface section into an equal number of triangular effector
tiles. For all simulations, an effector tile density of 104 tiles/Am2 was specified.
Thus, each triangular effector tile had a surface area of 100 nm2. Desired
VEGFR1 and VEGFR2 receptor densities are specified (5, 25 or 125 per Am2),
and a random number generator determines whether or not a particular effector
tile should be labeled as a receptor. Each Monte Carlo run uses a different seed
value to generate a new random number stream, resulting in variability in the
number of receptors produced. This variability is accounted for in interpreting
the results (see Results). Seed values which result in zero receptors were
discarded.
Three ligand concentrations were used for VEGF165: 20 pM, 200 pM and 2
nM. These molar concentrations equate to approximately 13, 120 and 1250
total ligands in the 1 Am1 Am1000 Am fluid column. For these three ligand
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spaced points along the vertical axis of the fluid column. In the 2 Am2
Am1000 Am fluid column, the same initial placement of ligands was used,
but with four 1 Am1 Am1000 Am fluid columns placed adjacent to each
other (ligands move freely between columns). The purpose of the initial
placement of ligands in a grid-like pattern is to provide a pseudo-uniform
concentration. The ligands were allowed time to equilibrate before binding
could begin.
2.4. Simulation execution
Simulations were executed for different elapsed times depending on the
ligand concentration. Systems with lower ligand concentrations took longer to
reach steady state. After the initial ligand placement, the simulation is executed
for 200 s (106 iterations), with all binding probabilities set to zero. During this
mixing period, the ligands diffuse without interacting with the cell surface.
Systematic non-uniformity from the initial placement of ligands is practically
eliminated by this mixing step. Binding probabilities are then set to their control
values and each simulation is run for a specified time. Simulations for different
sets of parameters (ligand concentrations, surface areas, receptor densities) are
executed for at least 30 and up to 100 different values of the random number
seed to ensure representative sampling; the actual number of runs for each
simulation is noted in the figure in which the results of that simulation first
appear.
2.5. Gillespie algorithm
To compare the results of the three-dimensional MCell simulation to a
simpler compartmental model, we used the Gillespie algorithm [13]. The total
numbers of VEGF (#V), VEGF receptor (#R), and VEGF-VEGF receptor
complexes (#VR) are tracked and the reaction rates are represented as
ron ¼ kon
Vol INA
LVð Þ LRð Þ
where the on rate is normalized by the volume (Vol) and Avogadro’s number
(NA), and
roff ¼ koff LVRð Þ
Two random numbers, p1 and p2, are generated. The time until the next reaction
is
Dt ¼ 1
ron þ roff log
1
p1

and the reactions take place as:
V ¼ V  1
R ¼ R 1
VR ¼ VRþ 1
)
p2V
ron
ron þ rof f
V ¼ V þ 1
R ¼ Rþ 1
VR ¼ VR 1
)
p2 >
ron
ron þ rof f
The numbers of molecules and reaction probabilities are then updated for the
next step. Monte Carlo implementation of the algorithm was written in
FORTRAN.
2.6. Model parameters
The same parameters are used in both the deterministic and stochastic
models. The fluid solution above the cell monolayer was assumed to be
aqueous. Thus, an aqueous diffusion coefficient DL of 2.0106 cm2/s was
used for deterministic and MCell simulations, based on the molecular weight of
VEGF [21]. The kinetics of VEGF binding to its receptors was obtained from
the literature; for VEGF165 and VEGFR1, kon and koff parameters were found to
be 4106 M1 s1 and 3105 s1, respectively, for a binding affinity of 7.5
pM [22]. The kon and koff values for VEGF165 and VEGFR2 were measured as
3.6106 M1 s1 and 1.34104 s1, respectively, for a binding affinity of
37 pM [23]. A time step of 2104 s per iteration was used for MCell
simulations. The time step is variable (randomly generated) in the Gillespie
algorithm.2.7. Data extraction and analysis methods
The raw data produced by the stochastic simulations is in the form of the
number of each species (i.e. free ligand, free receptor, bound receptor) present
at each timepoint. FORTRAN programs are used to sort data from different
runs and compute the variables of interest—the mean fractional occupancy, and
the coefficient of variation (CV=j/l, where r is the standard deviation and l
is the mean). The mean and variation over time are plotted, with particular
focus on the values of these variables at steady state and at 5–10 min post-
VEGF addition. This latter condition represents the time at which peak
phosphorylation of VEGF receptors is typically observed.3. Results
3.1. One receptor: VEGFR2
VEGFR2 is the main signaling receptor for VEGF on
endothelial cells; phosphorylation of VEGFR1 is not as strong.
We examine first the binding of VEGF to this receptor
expressed alone on endothelial cells in vitro. This represents
a realistic experimental situation, e.g., the expression of
VEGFR2 on porcine aortic endothelial cells, which do not
have other VEGF receptors. For a 1 Am2 patch of cell
membrane, containing on average 25 receptors (equivalent to
25,000 receptors/cell), the mean of the stochastic results for the
fractional occupancy of VEGFR2 fit well to the deterministic
results at 200 pM initial VEGF concentration (Fig. 1A).
However, at lower initial VEGF concentrations, e.g., 20 pM,
there is a deviation between the stochastic result and the
deterministic prediction. This discrepancy is not decreased by
increasing the number of runs of the MCell software (100 runs
are used in Fig. 1A), but is alleviated by running the stochastic
simulation for a 4 Am2 patch of membrane (Fig. 1C),
suggesting that the problem may be related not to the
concentration, but to the total number of ligands involved in
the simulation. The number of free ligands available for
binding at steady state is predicted to be 98 for 200 pM, but
only 7 for 20 pM in the 1 Am2 configuration, rising to 28 for
the 4 Am2 area. For the smaller number of ligands, the large
volume (1000 Am3) means that most of these ligands will not
be close to the surface, resulting in a very small ligand number
available for binding, possibly less than one on average. This
would be a source of discrepancy between the deterministic
and stochastic models, as the stochastic model will have either
zero or one ligands present, with very different outcomes for
each; the deterministic model allows concentrations between
zero and one molecules which deals smoothly (though possibly
inaccurately) with the situation.
At higher concentrations, e.g., 2 nM, the stochastic
simulation appears to deviate again for a 1 Am2 patch (Fig.
1A), but now the deterministic result underestimates the true
binding to the receptors. The stochastic results at 4 Am2 agree
with the deterministic (Fig. 1C). The number of ligands should
be sufficient to approximate the binding, so this suggests that
the number of receptors may also be important. Since the
number of receptors is the same at all concentrations, the
number of free receptors which are available for binding is
likely to be affecting the result. For 20 pM, the average density
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pM, 4.8 Am2; at 2 nM, 0.5 Am2. For 4 Am2, the total number
of free receptors is four times larger, bringing the 2 nMsimulation out of the problem of having less than one free
receptor on average. The same argument as for ligand
concentration above applies to these small concentrations and
Fig. 2. Binding of VEGF to a monolayer of cells expressing 25,000 VEGFR2 per cell. (A) Fractional occupancy of VEGFR2 at steady state for increasing VEGF
concentrations; deterministic results (dotted line) agree well with the MCell stochastic results for 1 Am2 (diamonds) only at 200 pM; stochastic results for 4 Am2
(squares) also agree well at 20 and 2000 pM. 1 Am2 area of larger membrane patch agrees with deterministic results at all concentrations shown. (B) Coefficient of
variation of the fractional occupancy decreases with increasing VEGF concentration; symbols as in A. (C and D) Fractional occupancy and coefficient of variation
averaged over 5–10 min post-VEGF addition; line and symbols as in A.
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models. Note that at intermediate concentrations, agreement is
seen at both patch sizes.
However, the 1 Am2 patch of membrane should not exist in
isolation. Therefore, we simulated a 4 Am2 patch, but tracked
the receptors in one 1 Am2 area to check if the discrepancy
persists. In this case, for both 20 pM and 2 nM VEGF, we
observe no significant deviation from the deterministic solution
(Fig. 1E, G). This suggests that the disagreement observed
earlier is an artifact of the small simulation volume. It remains
an open question whether significant clustering—VEGFFig. 1. Binding of VEGF to a monolayer of cells expressing 25,000 VEGFR2 per cel
and 2000 pM initial VEGF concentration, for a membrane patch of 1 Am2. Determ
Carlo stochastic simulations using MCell (jagged lines). For stochastic simulation
following addition of VEGF for the stochastic simulations in A. (C) Fractional o
deterministic (smooth lines) and MCell (jagged lines) results are shown. For stochas
variation of the fractional occupancy over time following addition of VEGF for th
following addition of 20 pM initial VEGF concentration for membrane patches of
shown. For subareas, n =100. (F) Coefficient of variation of the fractional occupanc
Fractional occupancy of VEGFR2 over time following addition of 2 nM initial VEGF
within the larger patch. MCell results shown. For subareas, n =100. (H) Coefficient
for the stochastic simulations in G.receptors surrounded by empty membrane area—would affect
the results.
The variance of the stochastic results was used to calculate
the coefficient of variation of the fractional occupancy (Fig.
1B, D). The variation in the binding to receptors can have a
meaningful effect where signaling and downstream responses
are based on a threshold level of activation [8]. Shortly after
growth factor addition, as binding begins, the variance is very
high, but it falls as binding equilibrates to a steady state level,
which depends on VEGF concentration but is significant at all
concentrations shown. The coefficient of variation decreasesl. (A) Fractional occupancy of VEGFR2 over time following addition of 20, 200
inistic model results (smooth lines) are shown overlaid on the results of Monte
s, n =100. (B) Coefficient of variation of the fractional occupancy over time
ccupancy of VEGFR2 over time for a membrane patch of 4 Am2. As in A,
tic simulations, n =68 (20 pM) and 30 (200 pM and 2 nM). (D) Coefficient of
e stochastic simulations in C. (E) Fractional occupancy of VEGFR2 over time
1 and 4 Am2, and for 1 and 3 Am2 areas within the larger patch. MCell results
y over time following addition of VEGF for the stochastic simulations in E. (G)
concentration for membrane patches of 1 and 4 Am2, and for 1 and 3 Am2 areas
of variation of the fractional occupancy over time following addition of VEGF
Fig. 3. Variability decreases with increasing receptor density. (A) Effect of variation in VEGFR2 concentration for 200 pM initial VEGF; MCell stochastic results
(jagged lines) match deterministic results (smooth lines) for 25,000 and 125,000 receptors/cell, but not for 5,000 receptors/cell (middle jagged line, top smooth line).
For stochastic simulations, n =80 (5,000), n =100 (25,000), n =73 (125,000). (B) Coefficient of variation for curves in A.
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the case of the 1 Am2 patch within a larger simulation area
(Fig. 1F, H), suggesting that the variability is not an artifact
of the discrepancies observed in small simulation volumes,
and may be significant over a larger surface area than shown
here.
The steady state and short time fractional occupancies
calculated from the deterministic model are shown to be close
approximations for the mean occupancies in the Monte Carlo
model (Fig. 2A and C). The coefficient of variation decreases
with increasing VEGF concentration, and with increasing
membrane patch size (Fig. 2B and D).
To investigate the effect of receptor number on the variance,
the simulation was run for 200 pM VEGF binding to a 1 Am2
patch of 5, 25 or 125 receptors (representing cells with 5000,
25,000 and 125,000 receptors). The deterministic model
predicts a decrease in fractional occupancy as the receptor
concentration increases (Fig. 3A). The stochastic model agrees
well at 25 and 125 receptors/Am2, but not for 5 receptors/Am2.
The number of unbound VEGF molecules is 39, 98 and 115,
which in line with earlier results should be sufficient for
agreement. The number of unbound receptors at steady state is
predicted to be approximately 25, 5 and 0.9 per Am2 for 125,
25 and 5 receptors/Am2, respectively. This small free receptor
number leads to the discrepancy between the deterministic and
stochastic models. 5000 receptors/cell would demonstrate 3.6
free receptors in a 4 Am2 membrane, allowing that simulation
to converge to the deterministic prediction (data not shown).
The coefficient of variation in the fractional occupancy
decreases with increasing receptor number (Fig. 3B).Fig. 4. Gillespie algorithm results match MCell and deterministic results. (A) Fracti
pM initial VEGF concentration, for a membrane patch of 1 Am2. Deterministic m
stochastic simulations using the Gillespie algorithm (jagged lines, n =100). (B) Coe
VEGF for the stochastic simulations in A. (C) Fractional occupancy of VEGFR2 ove
MCell (jagged lines, n =100) results are shown. (D) Coefficient of variation of the
simulations in C. (E) Coefficient of variation at steady state decreases with increasing
algorithm (open symbols) and MCell (closed symbols) shown. (F) Coefficient of var
decreases with VEGF concentration but not with total surface area when tracking rec
subarea of larger membrane patch.3.2. Variation in receptor number does not account for the
variability in binding
The allocation of the receptors by the MCell program
introduces variability into the results; this is why we used
the fractional occupancy. The fractional occupancy should be
less susceptible to the receptor number variations than the
ligand–receptor complex number. For the 1 Am2 simulations,
the coefficient of variation of the receptor number was 18%;
for 4 Am2, 10%. However, the effect on fractional
occupancy of this variation in receptor number is progres-
sively smaller as the number of ligands added initially
becomes greater; for 20 pM, the fractional occupancy would
show a coefficient of variation of 7.5% (or 4.1% for 4 Am2);
200 pM, 0.7%; 2 nM, less than 0.01%. For each concen-
tration, we note that the observed coefficient of variation is
at all times larger than these predictions (Fig. 1B, D, F, H),
and the remainder is assumed to be non-receptor number-
related variance.
3.3. Gillespie algorithm: one receptor
To verify the results of the MCell software, we used a
second method to stochastically simulate the ligand–receptor
binding, without including the three-dimensional motion of
VEGF molecules. Using this algorithm, the mean fractional
occupancy for 1 Am2 (Fig. 4A) and 4 Am2 (Fig. 4C) are the
same and agree with the deterministic results. The coefficient
of variation (Fig. 4B, D) is in close agreement with that
predicted by MCell simulations (Fig. 1B, D) with the exceptiononal occupancy of VEGFR2 over time following addition of 20, 200 and 2000
odel results (smooth lines) are shown overlaid on the results of Monte Carlo
fficient of variation of the fractional occupancy over time following addition of
r time for a membrane patch of 4 Am2. As in A, deterministic (smooth lines) and
fractional occupancy over time following addition of VEGF for the stochastic
VEGF concentration and increasing surface area of membrane patch. Gillespie
iation at 5–10 min, symbols as in E. (G) Coefficient of variation at steady state
eptors in a 1 Am2 subarea. (H) Coefficient of variation at 5–10 min for a 1 Am2
F. Mac Gabhann et al. / Biochimica et Biophysica Acta 1746 (2005) 95–107 101of 20 pM VEGF for a 1 Am2 patch, where the Gillespie
algorithm predicts lower variability than MCell; this is likely
due to the availability of all VEGF to bind receptors in theGillespie algorithm, where VEGF molecules may be distant
from the surface in the MCell simulations. When the 1 Am2
patch was studied as part of a larger area using MCell (Fig. 1F),
F. Mac Gabhann et al. / Biochimica et Biophysica Acta 1746 (2005) 95–107102the variability found was the same as that predicted by the
Gillespie algorithm for 1 Am2.
Using the Gillespie algorithm, we then investigated the
impact of membrane area on the coefficient of variation of the
fractional occupancy (Fig. 4E, F). Even over a large surface
area equivalent to a full endothelial cell (¨1000 Am2) the
variability in binding at the time of peak phosphorylation (5–
10 min) is greater than 1% for VEGF concentrations below 200
pM. While tracking a subset of receptors equivalent to a 1 Am2
patch of membrane, we increased the total number of receptors
but found no change in the variability in binding in the small
patch (Fig. 4G–H), explaining the agreement between the 1
Am2 in 4 Am2 MCell results and the 1 Am2 Gillespie results.
This suggests that signal integration at the local level just
within the membrane will demonstrate considerable variability:
5% to 50% at steady state (10% to 150% at 5–10 min) for
initial VEGF concentrations less than 1 nM.
3.4. Two receptors: VEGFR1 and VEGFR2
We next simulate a cell with equal densities of VEGFR1 and
VEGFR2. These two receptors have differing kinetics for VEGF,
VEGFR1 having greater affinity than VEGFR2. For a 1 Am2
patch of membrane (data not shown), the deterministic and
MCell stochastic models agree well at 200 pMVEGF. However,
as before, at 20 pM significant deviation from the predicted
occupancies of both receptors is observed. This deviation
vanishes when the simulations are run for a 4 Am2 area (Fig.
5A). The variability again decreases with increasing VEGF
concentration (Fig. 5B). The variability in fractional occupancy
of VEGFR2 is consistently higher than that of VEGFR1,
presumably reflecting the decreased affinity for VEGFR2
relative to VEGFR1. Note also that the mean fractional
occupancy of VEGFR2 and its coefficient of variation are both
slightly reduced by the presence of VEGFR1 (compare Fig. 5A–
B to Fig. 1C–D). The variability in binding to the receptors is
higher at earlier times (Fig. 5E–F). At 2 nM, there is a
discrepancy between the deterministic and MCell stochastic
results for a 1 Am2membrane patch, though less in this case than
for a single receptor due to a higher total concentration of
receptors. The Gillespie algorithm again reproduces the results
of the MCell simulation at 4 Am2 (Fig. 5C, D).
The receptors for VEGF are not typically present in
equimolar quantities on the endothelial cell surface, however.
We simulated a cell with 5000 VEGFR1 receptors and 25,000
VEGFR2s. For a 1 Am2 patch of membrane, we again see
significant deviation from the deterministic model predictions
for the stochastic results at low VEGF concentrations (data not
shown), and these differences again disappear for a 4 Am2
membrane area (Fig. 6A). We see variabilities in excess of
those predicted by receptor variation (Fig. 6B), and the
variability of VEGFR1 is now higher than that of VEGFR2.
Predictions of the Gillespie algorithm for 4 Am2 (Fig. 6C, D)
match the results of the MCell simulation. To further test our
hypothesis that the discrepancies between the MCell stochastic
and deterministic results can be ligand–number dependent, we
noted that for 20 pM, the 1 Am2 patch had divergent stochasticand deterministic results, while the 4 Am2 patch results agreed.
The mean numbers of free ligands for these situations at steady
state were 7 and 21, respectively. We then constructed
simulations which would result in 7 free ligands for the 4
Am2 patch, and 21 for the 1 Am2 patch (6 pM and 57 pM,
respectively). The higher concentration 1 Am2 patch agreed
with the deterministic results; the lower concentration 4 Am2
patch now diverged. We conclude that free ligand number is
important to the consistency of deterministic and MCell
stochastic results, just as free receptor number was shown to
be earlier. The steady state and short-time variance at these
concentrations is in line with the predictions for other
concentrations (Fig. 6E–F).
3.5. Dimerization of VEGF receptors
VEGF is a dimeric protein with two binding sites for
receptor monomers, one at each pole of the protein. The
mechanism of dimerization is not known, but it is possible that
the mechanism affects the variability in signaling. We compare
the 1:1 ligand–receptor binding model to several possible
mechanisms of dimerization: SPD, static pre-dimerization
(ligand binds two predimerized receptor monomers); DPD,
dynamic pre-dimerization (receptors dimerize and dissociate
independent of ligand); and LID, ligand-induced dimerization
(ligand binds receptor monomer, then binds second monomer)
[24]. We applied the Gillespie algorithm and found that the
average fractional occupancy for each mechanism matches the
deterministic model (Fig. 7A, B) and that the variability in the
binding is similar for each dimerization mechanism, and
similar to the simple 1:1 binding model (Fig. 7C). Only
ligand-induced dimerization of non-associating receptor mono-
mers demonstrated a slightly lower variability.
3.6. Single-receptor bound probability and variability
With the fractional occupancy and coefficient of variation of
an ensemble of receptors (5 or 25 for 1 Am2, 20 or 100 for 4
Am2) known, what is the probability of any one receptor being
bound at a point in time, and what is the variance associated
with that? Assuming each receptor has the same probability p
of being bound to a ligand, the variance associated with this is
pI(1p) as each receptor can only be in one of two states,
bound or unbound. For n total receptors the expected value of
the number of bound receptors is l =n Ip, and that of the
fractional occupancy is lu=l/n =p. The variance of the
number of bound receptors is r2=nIpI(1p), and the variance
in the fractional occupancy is thus ru
2= ( p I (1p))/n. Note that
the fractional occupancy and the bound probability are
identical; the variance decreases with 1/n, so that the
coefficient of variation for a single receptor can be related to
the observed coefficient for n receptors as CV1 ¼
ﬃﬃﬃ
n
p
ICVn.
This analysis assumes each receptor acts independently. The
single-receptor coefficient of variation for Gillespie algorithm
simulation of many ligand–receptor concentration combina-
tions is shown in Fig. 8, along with the results of several MCell
simulations. Note that the steady-state variability is almost
Fig. 5. Binding of VEGF to a monolayer of cells expressing 25,000 VEGFR2 and 25,000 VEGFR1 per cell. (A) Fractional occupancy of VEGFR2 (dotted lines)
and VEGFR1 (solid lines) over time following addition of 20 and 200 pM VEGF, for 4 Am2 cell surface area. Deterministic (smooth lines) and MCell stochastic
(jagged lines) curves are overlaid. For stochastic simulations, n =94 (20 pM), n =35 (200 pM). (B) Coefficient of variation for stochastic curves shown in A. (C)
As in A but showing Gillespie algorithm stochastic results (n =100). (D) Coefficient of variation for stochastic curves shown in C. (E) Steady state coefficient of
variation of the fractional occupancy, MCell stochastic results on 1 Am2 (diamonds) and 4 Am2 (squares) shown for VEGFR1 (solid symbols) and VEGFR2 (open
symbols). For 1 Am2 simulations, n =70 (20 pM), n =47 (200 pM) and n =73 (2 nM). (F) Coefficient of variation averaged over 5–10 min post-VEGF addition;
symbols as in E.
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not shown). Thus, the overall coefficient of variability varies
approximately with the square root of receptor density. We
would expect the variability to increase at higher receptor
densities, as the cell sequestered more of the ligand and the
fractional occupancy of the receptors decreased, but this is notobserved: calculating the variability of binding from the free
ligand concentration, rather than directly from the results, leads
to an overestimation of the variation (lines, Fig. 8A). On the
other hand, calculation of variability based on free ligand
concentration at early times significantly underestimates the
variation (Fig. 8B).
Fig. 6. Binding of VEGF to a monolayer of cells expressing 25,000 VEGFR2 and 5000 VEGFR1 per cell. (A) Fractional occupancy of VEGFR2 (dotted lines) and
VEGFR1 (solid lines) over time following addition of 20 and 200 pM VEGF, for 4 Am2 cell surface area. Deterministic (smooth lines) and MCell stochastic (jagged
lines) results are overlaid. For stochastic simulations, n =95 (20 pM), n =35 (200 pM). (B) Coefficient of variation for stochastic curves shown in A. (C) As in A but
Gillespie algorithm stochastic results (n =100). (D) Coefficient of variation for stochastic curves shown in C. (E) Steady state coefficient of variation of the fractional
occupancy, MCell stochastic results on 1 Am2 (diamonds) and 4 Am2 (squares) shown for VEGFR1 (solid symbols) and VEGFR2 (open symbols). For 1 Am2
simulations, n =69 (20 pM), n =88 (57 pM), n =48 (200 pM), n =71 (2 nM); for 4 mm2, n =92 (6.2 pM). (F) Coefficient of variation averaged over 5–10 min post-
VEGF addition; symbols as in E.
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by exposing a single receptor to ligand; the variability (and the
occupancy probability) includes the information of the density of
receptors around the receptor of interest. Because of this, such a
single-receptor simulation could not be interpreted to find the
variability of the fractional occupancy of a receptor ensemble.3.7. Temporal integration
Cells may attempt to smooth the variations in receptor
binding by integrating over space as described earlier. Another
strategy would be to integrate the signal over time. To mimic
the consequences of this, we applied a Fsliding window_
Fig. 7. Dimerization of VEGF receptors does not significantly affect variability. (A) Fractional occupancy of VEGFR2, deterministic results for 200 pM VEGF
and 25,000 VEGFR2 per cell. 1:1, simple Langmuir ligand– receptor binding; SPD, static pre-dimerization (ligand binds two predimerized receptor monomers);
DPD, dynamic pre-dimerization (receptors dimerize and dissociate independent of ligand); LID, ligand-induced dimerization (ligand binds receptor monomer,
then binds second monomer). (B) Fractional occupancy of VEGFR2, stochastic results using Gillespie algorithm (n =100). (C) Coefficient of variation for
stochastic results in B.
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The new data were then compiled to find the mean fractional
occupancy and the coefficient of variation of the time-
integrated data. For a window of 1 h, the mean fractional
occupancy, as expected, followed the trend of the unintegrated
results, though smoothed and with a time lag (Fig. 9A).
Windows of 6 s, 60 s and 600 s yielded results that were
indistinguishable from the original results at this scale (data not
shown). Despite the smoothing of the curve, the coefficient of
variation for these time-integrated results was also relatively
unchanged from the original results (Fig. 9B), suggesting that
the majority of the variation observed is between runs of the
simulation rather than between timepoints in the same run.
Shorter time windows were not significantly different from the
original. Temporal integration was performed on other single
and double receptor simulation results and similar results were
found.Fig. 8. Single receptor binding variability. (A) Coefficient of variation at steady s
Gillespie algorithm (open symbols, n =100) and MCell (closed symbols). Variabi
Coefficient of variation averaged over 5–10 min post-VEGF addition. Notation as4. Discussion
We have investigated the behavior of VEGF–VEGF
receptor binding to endothelial cells using deterministic and
stochastic methods, looking in particular at the area over which
the cell is Fintegrating_ the signals from its activated receptors.
Cells cannot respond independently to each ligand–receptor
binding event; with a population of several thousand receptors,
the cell must integrate the signal at some point in signal
transduction. The extent of the integration may depend on the
signal pathway, for example, proliferation may be the result of
integrating cues from the entire cell surface, whereas chemo-
tactic or haptotactic migration may require the comparison of
signals from different parts of the same cell, and the integration
would thus be over a smaller area. We also note that the
receptors on cells tend to cluster rather than be distributed
throughout the plasma membrane. Clusters of VEGFR2tate for varying initial VEGF concentration and VEGF receptor density using
lity calculated using the free ligand concentration is also shown (lines). (B)
in A.
Fig. 9. Temporal integration does not decrease the coefficient of variation. A sliding window average of each stochastic MCell simulation was taken, and the
fractional occupancy mean and variance recalculated. (A) Mean fractional occupancy of the temporally integrated (1 h) data for VEGFR1 (solid line) and VEGFR2
(dotted line); simulation for 5000 VEGFR1, 25,000 VEGFR2 and 20 pM VEGF on a 4 Am2 membrane. Shorter window times up to 10 min were not distinguishable
from the original (see text). (B) Coefficient of variation of the integrated results. Lines as in A.
Fig. 10. Low receptor number and low ligand concentration increase variability
Schematic shows that when total number of receptors increases, variability o
ligand– receptor binding (shading) declines. The total number of receptors can
be affected both by receptor concentration and the area over which the signal is
being integrated by the cell. Increasing the ligand concentration also decreases
variability.
F. Mac Gabhann et al. / Biochimica et Biophysica Acta 1746 (2005) 95–107106observed on endothelial cells in vitro were of 4–6 Am2 area,
and covered 20% of the cell surface area [25], implying a five-
fold concentrating of receptors.
The continuum approximation is useful for the study of
molecular interactions when the species in question are not
present in extremely small quantities and individual molecules
can be represented instead as concentrations. VEGF binds to
several receptors on the surface of endothelial cells, and our
goal in this study was to compare deterministic models built
using the continuum approximation to stochastic models
where all molecules are explicitly represented. We tracked
the fractional occupancy of the VEGF receptors over time in
response to VEGF addition to the medium above a monolayer
of cells. We used two Monte Carlo methods, one which tracks
individual molecules in 3D space and one which does not.
For the first model type (using MCell software), we found
that the agreement between the stochastic and deterministic
results depended upon the area over which the fractional
occupancy is averaged, which is equivalent to the area over
which the cell is integrating the signals from its activated
receptors. However when considered as part of a larger area,
discrepancies between the models disappeared at typical
ligand concentrations and receptor densities. For the second
stochastic model type (employing the Gillespie algorithm),
results agree with the deterministic models over all areas,
ligand and receptor densities tested. We conclude that the
deterministic models are suitable for simulating in vitro
experiments of VEGF–VEGF receptor system on endothelial
cells.
As well as the agreement of fractional occupancy predic-
tions of stochastic and deterministic models, we also measured
the variability of binding using the stochastic models. The
variability, as measured by the coefficient of variation, was
shown to be highly dependent on ligand and receptor
concentrations (Fig. 10). It was also higher at early times,
which has implications for periods of peak phosphorylation,
but could also hold a significant steady state value. Variabilitywas not reduced by introducing temporal integration of the
binding, nor by the inclusion of any of several mechanisms of
receptor dimerization. Increasing the area of integration—
which, like increasing receptor density, increases the total
number of receptors being integrated—does reduce variability;
however any size subpatch within that area will have higher
variability than the patch as a whole. The two stochastic model
types used here show agreement in the predicted variability of
binding. This agreement indicates that the VEGF gradients are
not significant enough in the cases studied here to cause
significant differences between the 3D and non-dimensional
models. Gradients would be increased by more receptors, faster
binding kinetics and/or slower ligand diffusion.
This demonstration of significant VEGF receptor binding
variability in vitro is for experiments at 4 -C, with no receptor
internalization or ligand secretion. While many experiments are
performed under these conditions, the analysis should be
repeated for room-temperature and body-temperature experi-.
f
F. Mac Gabhann et al. / Biochimica et Biophysica Acta 1746 (2005) 95–107 107ments, including both of these cell-surface processes. Gradients
of VEGF are expected to be greater than observed here,
requiring the use of three-dimensional MCell simulations rather
than the non-dimensional Gillespie method. The comparison
should also be extended to the in vivo situation. The volume
available for ligand transport in vivo (extracellular space) per
surface area of endothelial cell is smaller than in vitro, thus the
number of molecules available at a given concentration is also
smaller. These scales mean that it is more likely in the in vivo
case that the continuum approximation may fail, and the
variability in VEGF–VEGFR binding will be even higher.
Such an extension should also take into account secretion of
VEGF from one cell type and binding to another, without the
bolus of initial VEGF seen in in vitro experiments. In addition,
the extracellular matrix affects the movement of growth factors,
both as a physical barrier to diffusion, and as a reservoir for
ligand binding.
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